Lifecore Biomedical, Inc. De (LFCR) Depreciation & Amortization (CF) (2010 - 2025)

Lifecore Biomedical's Depreciation & Amortization (CF) history runs 16 years deep, the most recent figure standing at $1.9 million for Q2 2025.

• In Q2 2025, Depreciation & Amortization (CF) fell 4.97% year-over-year to $1.9 million; the TTM figure through May 2025 stood at $8.0 million (up 0.92% YoY), while the FY2025 annual figure was $8.0 million, up 0.92% from the prior year.
• Depreciation & Amortization (CF) was $1.9 million for Q2 2025 at Lifecore Biomedical, down from $2.1 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $5.9 million in Q4 2021 to a low of $1.8 million in Q4 2023.
• Historically, Depreciation & Amortization (CF) has averaged $3.2 million across 5 years, with a median of $2.8 million in 2022.
• The sharpest annual moves came in 2021 and 2022: Depreciation & Amortization (CF) advanced 25.51% in 2021, then plunged 50.41% in 2022.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $5.9 million in 2021, then slumped by 50.41% to $2.9 million in 2022, then plunged by 39.93% to $1.8 million in 2023, then grew by 15.74% to $2.0 million in 2024, then slipped by 6.36% to $1.9 million in 2025.
• The last three Depreciation & Amortization (CF) figures came in at $1.9 million (Q2 2025), $2.1 million (Q1 2025), and $2.0 million (Q4 2024), per Business Quant data.